Edwards Lifesciences Discloses Possible FCPA Issue
Edwards Lifesciences, a company developing treatments for structural heart disease, and critical care and surgical monitoring, is under FCPA scrutiny after voluntarily notifying the SEC and DOJ that it is conducting an internal investigation.
🔒 Members Only · Compliance & Enforcement BriefYou’ve reached the member portion of this brief.Members read the full analysis and the source documents in every case digest, six days a week.
$750/year